How do I transition from active treatment to surveillance for Lymphoma

Transitioning from Active Treatment to Surveillance for Lymphoma

This is an important question that many lymphoma patients face. Let me explain how this transition typically works and what you should discuss with your care team.

How Doctors Approach the Transition

According to NCCN Guidelines, the shift from active treatment to surveillance depends on several factors:

1. Achieving Remission First Your oncology team will confirm that your lymphoma has responded well to treatment. This usually means:

• Imaging tests (CT or PET scans) show no evidence of cancer
• Blood work returns to normal ranges
• You've completed your planned treatment course

2. Type of Lymphoma Matters Different lymphoma types have different surveillance approaches:

• Indolent (slow-growing) lymphomas like follicular lymphoma may have longer surveillance intervals
• Aggressive lymphomas like diffuse large B-cell lymphoma (DLBCL) typically have more frequent monitoring initially, then spacing out over time

3. Molecular Residual Disease (MRD) Testing A newer development in lymphoma care is MRD testing, which detects remaining cancer cells in your blood using circulating tumor DNA (ctDNA). According to recent NCCN Guidelines for B-Cell Lymphomas (December 2024), MRD testing can help guide surveillance schedules. Tests like the Foresight CLARITY Lymphoma can detect relapse approximately 6-7 months earlier than PET/CT imaging in DLBCL patients, which may help personalize your follow-up plan.

What Surveillance Typically Looks Like

Initial Phase (First 1-2 years):

• More frequent clinic visits (every 3 months)
• Regular physical exams
• Periodic imaging (CT or PET scans) - frequency depends on your lymphoma type
• Blood work to monitor for relapse

Later Phase (Years 2+):

• Visits may space out to every 6 months or annually
• Imaging becomes less frequent if you remain in remission
• Continued blood work monitoring

Key Questions to Ask Your Oncology Team

1. What does remission mean for my specific type of lymphoma? (Ask about complete vs. partial remission)

2. What is my surveillance schedule? When will I have follow-up visits, imaging, and blood work?

3. Will MRD testing be part of my surveillance plan? If so, how will results guide my care?

4. What symptoms should I watch for between appointments? (Swollen lymph nodes, fever, night sweats, unexplained weight loss, fatigue)

5. How long will surveillance continue? (This varies by lymphoma type and individual factors)

6. What happens if imaging or blood work shows changes? (Discuss the plan if relapse is detected)

7. Are there any clinical trials I should consider? (Especially relevant if you had aggressive lymphoma or didn't achieve complete remission)

What You Should Know About Surveillance

• It's not "doing nothing" — regular monitoring is active cancer care
• Surveillance schedules can change based on how you're doing
• Report new symptoms promptly — don't wait for your next scheduled visit if you notice swollen lymph nodes, persistent fever, or other concerning changes
• Emotional transition is real — moving from frequent appointments to less frequent ones can feel both relieving and anxiety-provoking; this is normal

Resources for More Information

The Lymphoma Research Foundation (lymphoma.org) and NCCN Guidelines for Patients on your specific lymphoma type provide detailed information about what to expect during surveillance.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.